These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15695488)

  • 1. Effects of micafungin on the morphology of Aspergillus fumigatus.
    Nishiyama Y; Hasumi Y; Ueda K; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2005 Jan; 54(1):67-77. PubMed ID: 15695488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.
    Choi JH; Brummer E; Stevens DA
    Microbes Infect; 2004 Apr; 6(4):383-9. PubMed ID: 15050966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing activity of micafungin against Aspergillus fumigatus hyphae assessed by specific fluorescent staining for cell viability.
    Watabe E; Nakai T; Matsumoto S; Ikeda F; Hatano K
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1995-8. PubMed ID: 12760883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.
    Chiou CC; Mavrogiorgos N; Tillem E; Hector R; Walsh TJ
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3310-21. PubMed ID: 11709302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin-Mediated Growth Inhibition and Paradoxical Growth in Aspergillus fumigatus Involve Fungicidal Hyphal Tip Lysis Coupled with Regenerative Intrahyphal Growth and Dynamic Changes in β-1,3-Glucan Synthase Localization.
    Moreno-Velásquez SD; Seidel C; Juvvadi PR; Steinbach WJ; Read ND
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.
    Kurtz MB; Heath IB; Marrinan J; Dreikorn S; Onishi J; Douglas C
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1480-9. PubMed ID: 7979276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide.
    Nishiyama Y; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2002; 51(4):247-55. PubMed ID: 12227555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
    Hatano K; Morishita Y; Nakai T; Ikeda F
    J Antibiot (Tokyo); 2002 Feb; 55(2):219-22. PubMed ID: 12003006
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.
    Arikan S; Yurdakul P; Hascelik G
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2640-3. PubMed ID: 12878531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm.
    Brun YF; Dennis CG; Greco WR; Bernacki RJ; Pera PJ; Bushey JJ; Youn RC; White DB; Segal BH
    Antimicrob Agents Chemother; 2007 May; 51(5):1804-12. PubMed ID: 17325217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice.
    Nakai T; Hatano K; Ikeda F; Shibuya K
    Med Mycol; 2005 Aug; 43(5):439-45. PubMed ID: 16178373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
    Loiko V; Wagener J
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic.
    Angiolella L; Maras B; Stringaro AR; Arancia G; Mondello F; Girolamo A; Palamara AT; Cassone A
    J Chemother; 2005 Aug; 17(4):409-16. PubMed ID: 16167521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 May; 18(9):2886-90. PubMed ID: 18424132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus.
    Steinbach WJ; Cramer RA; Perfect BZ; Henn C; Nielsen K; Heitman J; Perfect JR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2979-81. PubMed ID: 17502415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2005 Nov; 56(5):887-92. PubMed ID: 16188916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
    Lamaris GA; Lewis RE; Chamilos G; May GS; Safdar A; Walsh TJ; Raad II; Kontoyiannis DP
    J Infect Dis; 2008 Jul; 198(2):186-92. PubMed ID: 18500936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum differentially alters the antifungal properties of echinocandin drugs.
    Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.